What should happen is the stock should be suspended and trading activity reviewed. ASXs non-action on this as it was rapidly rising on massive volumes was farcical.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025